SOURCE: Pharm Control Ltd.

April 27, 2007 09:30 ET

Pharm Control Shareholder Update

NEW YORK, NY -- (MARKET WIRE) -- April 27, 2007 -- Pharm Control (PINKSHEETS: PMCL) would like to update its shareholders by advising that the Company anticipates the name change to Natural Medications Inc., the new CUSIP and new symbol to be processed by some time in early May 2007.

In addition, the Board of Directors increased the Authorized Shares to 1 billion in order to have the flexibility of possible financings in the future but also to pursue acquisitions, particularly manufacturing facilities in Southeast Asia.

As part of this potential growth, the Company is looking into listing the Company for trading in overseas markets with an emphasis on South East Asia.

About Pharm Control Ltd.

Pharm Control Ltd. is a leading medicine Research and Development company that is devoted to developing medicines that allow patients to live longer, healthier, and more productive lives. The Company's founders have invested over 10 years of research discovering and developing new and effective non-synthetic medicines to fight disorders and sickness in the modern world.

Safe Harbor Statement

The preceding includes forward-looking statements, which involve known and unknown risks, and uncertainties, which may cause the company's actual results in future periods to differ materially from forecasted results. Any forward-looking statements above are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to a variety of factors, including, without limitation, competition, intellectual property rights, litigation, needs of liquidity, and other risks detailed from time to time in the company's reports filed with the SEC. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, but not limited to, continued acceptance of the company's products and services, competition, new products and technological changes, as well as any and all "other risks" associated with business.

Contact Information

  • Contact:

    Pharm Control Ltd.
    Eugene Kron
    Vice President
    Tel: (212) 252-4521